ADRA2C |
ADRA2C, ADRA2L2, ADRA2RL2: Alpha-2C adrenergic receptor |
RGS17 |
RGS17: Regulator of G-protein signaling 17 |
1.425 |
Evidence |
|
RGS5 |
RGS5: Regulator of G-protein signaling 5 |
HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
1.425 |
Evidence |
|
RGS16 |
RGS16, RGSR: Regulator of G-protein signaling 16 |
EDG5 |
EDG5: Sphingosine 1-phosphate receptor Edg-5 |
1.425 |
Evidence |
|
MTNR1A |
MTNR1A: Melatonin receptor type 1A |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
1.425 |
Evidence |
|
SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
CD79A |
CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain |
1.425 |
Evidence |
|
RGS16 |
RGS16, RGSR: Regulator of G-protein signaling 16 |
ADRA2A |
IPI00031712 |
1.425 |
Evidence |
|
APS |
SH2B2, APS: SH2B adapter protein 2 |
FCER1G |
FCER1G: High affinity immunoglobulin epsilon receptor subunit gamma precursor |
1.425 |
Evidence |
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
SCAP2 |
SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 |
1.425 |
Evidence |
|
RGS5 |
RGS5: Regulator of G-protein signaling 5 |
C14orf21 |
LTB4R2, BLT2R, BLTR2: Leukotriene B4 receptor 2 |
1.425 |
Evidence |
|
RGS16 |
RGS16, RGSR: Regulator of G-protein signaling 16 |
MTNR1A |
MTNR1A: Melatonin receptor type 1A |
1.425 |
Evidence |
|
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
HRH4 |
HRH4, GPCR105: Histamine H4 receptor |
1.425 |
Evidence |
|
SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
CSF2RB |
CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor |
1.425 |
Evidence |
|
RGS5 |
RGS5: Regulator of G-protein signaling 5 |
ADRA2C |
ADRA2C, ADRA2L2, ADRA2RL2: Alpha-2C adrenergic receptor |
1.425 |
Evidence |
|
RGS13 |
RGS13: Regulator of G-protein signaling 13 |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
1.425 |
Evidence |
|
IFNA8 |
IFNA8: Interferon alpha-8 precursor |
IL27RA |
IPI00006774 |
1.425 |
Evidence |
|
SIAH2 |
SIAH2: E3 ubiquitin-protein ligase SIAH2 |
TNFRSF7 |
CD27, TNFRSF7: CD27 antigen precursor |
1.425 |
Evidence |
|
RGS16 |
RGS16, RGSR: Regulator of G-protein signaling 16 |
AGTR2 |
AGTR2: Type-2 angiotensin II receptor |
1.425 |
Evidence |
|
PSMD1 |
PSMD1: 26S proteasome non-ATPase regulatory subunit 1 |
PCDHGB4 |
IPI00028619 |
1.425 |
Evidence |
|
EGF |
EGF: Pro-epidermal growth factor precursor |
GRB7 |
GRB7: Growth factor receptor-bound protein 7 |
1.425 |
Evidence |
|
RGS5 |
RGS5: Regulator of G-protein signaling 5 |
EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
1.425 |
Evidence |
|
RGS13 |
RGS13: Regulator of G-protein signaling 13 |
HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
1.425 |
Evidence |
|
MNDA |
MNDA: Myeloid cell nuclear differentiation antigen |
CASP10 |
IPI00290791 |
1.425 |
Evidence |
|
GALR2 |
GALR2, GALNR2: Galanin receptor type 2 |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
1.425 |
Evidence |
|
RGS16 |
RGS16, RGSR: Regulator of G-protein signaling 16 |
GPR88 |
GPR88, STRG: Probable G-protein coupled receptor 88 |
1.425 |
Evidence |
|
TNFRSF11B |
TNFRSF11B, OCIF, OPG: Tumor necrosis factor receptor superfamily member 11B prec |
TNFRSF10C |
TNFRSF10C, DCR1, UNQ321/PRO366, LIT, TRAILR3, TRID: Tumor necrosis factor recept |
1.425 |
Evidence |
|